Primitive Neuroectodermal Tumor — Trials

Primitive Neuroectodermal Tumor — Trials · CancerIndex

Clinical trials

Registered studies

673 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 146
Recruiting: 80
Ph III recruiting: 8
Growth YoY: −33.3%
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (86)

clinicaltrialsPublishedShowing 551–600 of 673 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00025428	Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma	completed	Phase 3	100	Societe Internationale d'Oncologie PediatriqueOTHER	12	Dec 4, 2013	clinicaltrials
NCT01986595	A Pilot Study on ALK Gene Mutations in Neuroblastoma	unknown	—	100	National Taiwan University HospitalOTHER	1	Nov 18, 2013	clinicaltrials